PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2815963

[Progress in wound drainage].

R Stücker·A Härle
View original source ↗Export metadata ↓

Abstract

The operative treatment today is standardized to a great extent, whereas postoperative drainage is still up to the own discretion of the surgeon. Important devices of drainage systems which are mandatory are highlighted. The most important point, a real closed wound drainage system, has not yet been introduced into clinical practice. Two drainage systems, which meet the demands of an effective wound drainage in different ways are presented. With regard to minimizing blood transfusion another system is described, which offers the possibility of reinfusion of drained blood to the patient.

Explore related subjects

Blood Transfusion, AutologousEquipment DesignHip ProsthesisHumansKnee ProsthesisOrthopedicsPostoperative CareSuctionEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Stücker, A Härle. [Progress in wound drainage].. https://doi.org/10.1055/s-2008-1044719

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel.

Application of autologous serum to treat a multitude of ocular surface diseases and conditions is a relatively new technique that has gained popularity over the past 10 years. This review focuses on the use of topical autologous serum and a new platelet gel delivery technique that utilizes autologous platelet concentrate mixed with calcium chloride and thrombin for gelling serum, which can then be applied easily to the corneal surface. Residual platelet serum concentrate can be mixed with artificial tears that are capable of gelling in a 25% concentrate, which is then used by the patient postoperatively. A review of the literature identifies various concentrations of autologous serum, frequency of application, and storage criteria.

Blood Transfusion, Autologous↗
PubMed2006

Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM).

BACKGROUND: An increased risk of postoperative infection (including pneumonia) attributable to the receipt of allogeneic blood transfusion has been investigated as a possible manifestation of transfusion-related immunomodulation (TRIM) in 16 randomized controlled trials (RCTs) and approximately 40 observational studies. OBJECTIVES: This review categorizes RCTs and observational studies with regard to the inference that they permit about possible mediators of TRIM-allogeneic white cells (WBCs), WBC-derived soluble mediators, and/or allogeneic plasma-and examines whether the totality of the clinical evidence supports an association between allogeneic blood transfusion and postoperative infection. RESULTS: When all available studies are considered together in meta-analyses, three types of studies show no increased risk of postoperative infection in association with allogeneic blood transfusion: a) RCTs comparing recipients of buffy-coat-reduced and prestorage-filtered, WBC-reduced allogeneic red cells; b) RCTs comparing recipients of allogeneic and autologous blood; and c) observational studies comparing patients transfused before and after implementation of WBC reduction. RCTs comparing recipients of nonbuffy-coat-reduced and WBC-reduced red blood cells may point to a TRIM effect, but they cannot yet be subjected to formal meta-analysis. CONCLUSIONS: No overwhelming clinical evidence has been presented to establish the existence of a TRIM effect that relates allogeneic blood transfusion to postoperative infection.

Blood Transfusion, Autologous↗